- Home
- » Tags
- » Guanoxabenz
Top View
- (19) United States (12) Reissued Patent (10) Patent Number: US RE41,998 E Campbell (45) Date of Reissued Patent: Dec
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2010/0196286 A1 ARMER Et Al
- Customs Tariff - Schedule
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Transdermal Device Containing
- ( 12 ) United States Patent
- Customs Tariff - Schedule Xxi - 1
- Bioactive Compound Library Plus (96-Well)
- Wo 2007/044693 A2
- Supplementary Information 0103 - 5053 $6.00+0.00 SI in Silico Antibacterial Activity Modeling Based on the TOMOCOMD-CARDD Approach Juan A
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Customs Tariff - Schedule Xxi - 1
- Noradrenergic Antidepressant Responses to Desipramine In&Nbsp
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- ICD-10-CM TABLE of DRUGS and CHEMICALS
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- 1111111111111111111Imnumu
- Pharmaceuticals Appendix
- ICD-10-CM Table of Drugs 2019
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- (12) United States Patent (10) Patent No.: US 8,697,361 B2 Johnson (45) Date of Patent: Apr
- Mydriasis Model in Rats As a Simple System to Evaluate Α2-Adrenergic
- (12) United States Patent (10) Patent No.: US 7,175,854 B2 Dietrich Et Al
- Α2 Adrenergic Receptor Dysregulation in Depressive Disorders